ATF3 plays a role in adipocyte hypoxia-mediated mitochondria dysfunction in obesity

Biochemical and Biophysical Research Communications

Volumn 431, Issue 3, 2013, Pages 421-427

  Jang, Min Kyung ^a   Son, Yonghae ^a   Jung, Myeong Ho ^a  

^a Pusan National University   (South Korea)

Author keywords

Activating transcription factor (ATF3); Adipose tissue hypoxia; Mitochondrial dysfunction; Nuclear respiratory factor 1 (NRF 1); Obesity

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ADENOSINE TRIPHOSPHATE; CYCLOOXYGENASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE TOLERANCE TEST; LIPID DIET; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

3T3-L1 CELLS; ACTIVATING TRANSCRIPTION FACTOR 3; ADIPOCYTES; ANIMALS; CELL HYPOXIA; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENES, MITOCHONDRIAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; OBESITY;

MUS;

EID: 84873732864     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.154     Document Type: Article

References (22)

1. Gesta S., Tseng Y.H., Kahn C.R. Developmental origin of fat: tracking obesity to its source. Cell 2007, 131(2):242-256.
2. Trayhurn P., Wang B., Wood I.S. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?. Br. J. Nutr. 2008, 100(2):227-235.
3. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56(4):901-911.
4. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9(5):67-77.
5. Ye J., Gao Z., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 2007, 293(4):E1118-E1128.
6. Trayhurn P P., Wang B., Wood I.S. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch. Physiol. Biochem. 2008, 114(4):267-276.
7. He Q., Gao Z., Yin J., Zhang J., Yun Z., Ye J. Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia. Am. J. Physiol. Endocrinol. Metab. 2011, 300(5):E877-E885.
8. Zhang H., Gao P., Fukuda R., Kumar G., Krishnamachary B., Zeller K.I., Dang C.V., Semenza G.L. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell. 2007, 11(5):407-420.
9. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3(3):177-185.
10. Wood I.S., Wang B., Lorente-Cebrián S., Trayhurn P. Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-d-glucose uptake in human adipocytes. Biochem. Biophys. Res. Commun. 2007, 361(2):468-473.
11. Keijer J., van Schothorst E.M. Adipose tissue failure and mitochondria as a possible target for improvement by bioactive food components. Curr. Opin. Lipidol. 2008, 19(1):4-10.
12. Wang C.H., Wang C.C., Wei Y.H. Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann. NY Acad. Sci. 2010, 1201:157-165.
13. Koh E.H., Park J.Y., Park H.S., Jeon M.J., Ryu J.W., Kim M., Kim S.Y., Lee K.U. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 2007, 56(12):2973-2981.
14. Hai T., Hartman M.G. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001, 273:1-11.
15. Hai T., Wolford C.C., Chang Y.S. ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component. Gene Expr. 2010, 15:1-11.
16. Kim H.B., Kong M., Kim T.M., Suh Y.H., Kim W.H., Lim J.H., Song J.H., Jung M.H. NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes. Diabetes 2006, 55:1342-1352.
17. Park H.J., Kang Y.M., Kim C.H., Jung M.H. ATF3 negatively regulates adiponectin receptor 1 expression. Biochem. Biophys. Res. Commun. 2010, 400:72-77.
18. Koh I.U., Lim J.H., Joe M.K., Kim W.H., Jung M.H., Yoon J.B., Song J. AdipoR2 is transcriptionally regulated by ER stress-inducible ATF3 in HepG2 human hepatocyte cells. FEBS J. 2010, 277:2304-2317.
19. Jang M.K., Kim C.H., Seong J.K., Jung M.H. ATF3 inhibits adipocyte differentiation of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 2012, 421(1):38-43.
20. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88(2):611-638.
21. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. (Lond) 2009, 33(1):54-66.
22. Flamment M., Hajduch E., Ferré P., Foufelle F. New insights into ER stress-induced insulin resistance. Trends Endocrinol. Metab. 2012, 23(8):381-390.